Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau-Reference-Cited by-同舟云学术

Circulating ethanolamine plasmalogen indices in Alzheimer's disease: Relation to diagnosis, cognition, and CSF tau

Published:2020-07-27 Issue:9 Volume:16 Page:1234-1247
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Kling Mitchel A.¹²,Goodenowe Dayan B.³,Senanayake Vijitha³,MahmoudianDehkordi Siamak⁴,Arnold Matthias⁴⁵,Massaro Tyler J.⁶,Baillie Rebecca⁷,Han Xianlin⁸,Leung Yuk‐Yee⁹,Saykin Andrew J.¹⁰,Nho Kwangsik¹⁰,Kueider‐Paisley Alexandra⁴,Tenenbaum Jessica D.¹¹,Wang Li‐San⁹,Shaw Leslie M.⁹,Trojanowski John Q.⁹,Kaddurah‐Daouk Rima F.⁴¹²¹³,

Affiliation:

1. Department of Psychiatry Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

2. Behavioral Health Service Crescenz VA Medical Center Philadelphia Pennsylvania USA

3. Prodrome Sciences Inc. Temecula California USA

4. Department of Psychiatry and Behavioral Sciences Duke University Durham North Carolina USA

5. Institute of Bioinformatics and Systems Biology Helmholtz Zentrum München, German Research Center for Environmental Health Neuherberg Germany

6. Duke Clinical Research Institute Duke University Durham North Carolina USA

7. Rosa & Co LLC San Carlos California USA

8. University of Texas Health Science Center at San Antonio San Antonio Texas USA

9. Department of Pathology and Laboratory Medicine Perelman School of Medicine University of Pennsylvania Philadelphia Pennsylvania USA

10. Department of Radiology and Imaging Sciences and the Indiana Alzheimer Disease Center Indiana University School of Medicine Indianapolis Indiana USA

11. Department of Biostatistics and Bioinformatics Duke University Durham North Carolina USA

12. Duke Institute of Brain Sciences Duke University Durham North Carolina USA

13. Department of Medicine Duke University Durham North Carolina USA

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/alz.12110

Reference46 articles.

1. 2016 Alzheimer's disease facts and figures

2. Plasma phospholipids identify antecedent memory impairment in older adults

3. Plasma Amyloid-β as a Predictor of Dementia and Cognitive Decline

4. Blood-Based Protein Biomarkers for Diagnosis of Alzheimer Disease

5. Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and validation of a plasmalogen score as an independent modifiable marker of metabolic health: population based observational studies and a placebo-controlled cross-over study;eBioMedicine;2024-07

2. Promising Strategies to Reduce the SARS-CoV-2 Amyloid Deposition in the Brain and Prevent COVID-19-Exacerbated Dementia and Alzheimer’s Disease;Pharmaceuticals;2024-06-16

3. Relationship between Plasma Lipid Profile and Cognitive Status in Early Alzheimer Disease;International Journal of Molecular Sciences;2024-05-13

4. Investigating the role of ethanolamine plasmalogen lipid in zebrafish brain by interdisciplinary lipidomics;2024-04-30

5. Therapeutic potential of a modified Mediterranean ketogenic diet in reversing the peripheral lipid signature of Alzheimer’s disease;2023-06-20